1. Rivero A., Polo R., Pérez Molina J.A. (editores). Documento de consenso de GeSIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana. Panel de expertos de GeSIDA y Plan Nacional sobre el Sida. (Actualización enero 2016.)
2. Lundgren J.D. (chair and coordinator). European Guidelines for treatment of HIV-infected adults in Europe. Version 8.0. October 2015.
3. Roy M., Gulick R.M., Hirsch M.S., Lane H.C. (co-chairs). Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Developed by the DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents. Last updated January 28, 2016.
4. Evaluating the role of atazanavir/cobicistat and darunavir/cobicistat fixed-dose combinations for the treatment of HIV-1 infection;Crutchley;HIV AIDS,2016
5. Cobicistat (GS-9350): A potent and selective inhibitor of human CYP3A as a novel pharmacoenhancer;Xu;ACS Med Chem Lett,2010